Atlas Trials

A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients

Clinical trial NCT02570854 · COMPLETED

Trial details

NCT number
NCT02570854
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anemia, Iron-Deficiency
Start date
2015-09-22
Primary completion
2020-05-13
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.